First Horizon Corporation’s Edwards Lifesciences EW Stock Holding History

First Horizon Corporation’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324K	Sell	3,583 -2,065	-37%	-$173K	0.01%	360
2026 Q1	$452K	Sell	5,648 -1,420	-20%	-$117K	0.02%	297
2025 Q4	$603K	Sell	7,068 -1,679	-19%	-$138K	0.03%	255
2025 Q3	$680K	Buy	+8,747	New	+$683K	0.03%	235
2021 Q2	$11.6M	Buy	111,706 +107	+0.1%	+$10.1K	1.04%	24
2021 Q1	$9.33M	Buy	111,599 +4,914	+5%	+$415K	0.89%	35
2020 Q4	$9.73M	Buy	106,685 +6,122	+6%	+$508K	0.96%	29
2020 Q3	$8.03M	Buy	+100,563	New	+$7.85M	0.86%	35

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

First Horizon Corporation's EW Position: Q2 2026 in Review

First Horizon Corporation reduced its Edwards Lifesciences (EW) stake by 37% in Q2 2026, selling an estimated $173K and leaving 3,583 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #360.

First Horizon Corporation first reported a position in EW in Q3 2020 and has held it in 8 quarters since. The position peaked at $11.6M in Q2 2021. 597 funds tracked by Wall St. Rank hold EW as of Q2 2026.

First Horizon Corporation held 3,583 shares of Edwards Lifesciences worth $324K as of Q2 2026.
First Horizon Corporation sold 2,065 Edwards Lifesciences shares in Q2 2026, an estimated $173K.
Edwards Lifesciences made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #360 holding.
First Horizon Corporation first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 8 quarters since.
First Horizon Corporation's Edwards Lifesciences position peaked at $11.6M in Q2 2021.
597 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.